SCHEDULE: FMR LLC Boosts Pulmonx Corp Stake to 10.6%
Schedule 13G Amendment
FMR LLC and Abigail P. Johnson have disclosed a 10.6% beneficial ownership stake in Pulmonx Corp common stock as of June 30, 2025.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 4,261,368 shares of Pulmonx Corp's common stock.
- This ownership represents 10.6% of the total outstanding common stock of Pulmonx Corp.
- FMR LLC holds sole voting power over 4,259,643 shares and sole dispositive power over 4,261,368 shares.
- Abigail P. Johnson holds sole dispositive power over 4,261,368 shares.
- FMR LLC is classified as a Parent Holding Company (HC), and Abigail P. Johnson is classified as an Individual (IN).
- The filing certifies that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Pulmonx Corp.
Sentiment
Score: 7
Explanation: The filing indicates a significant and stable institutional ownership stake by a major investment firm, which is generally viewed positively as a vote of confidence in the company. While it's a factual disclosure without explicit performance metrics, the presence of a large, long-term investor like FMR LLC can be a positive signal for other market participants.
Positives
- Significant institutional ownership by FMR LLC, a major investment management firm, may signal confidence in Pulmonx Corp's long-term prospects.
- The disclosure indicates a substantial stake, which can attract further investor interest.
Risks
- The concentration of a significant portion of voting and dispositive power with a single entity (FMR LLC) and its affiliates could potentially influence future corporate decisions, though the filing states no intent to influence control.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding Pulmonx Corp's future financial performance or strategic outlook.
Management Comments
- Richard Bourgelas, Duly authorized under Power of Attorney, certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
This Schedule 13G filing indicates a significant institutional investment in Pulmonx Corp, a company operating in the medical device sector. Such filings are standard disclosures for investors acquiring more than 5% of a company's stock, providing transparency on major ownership stakes within the market.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Control Structure Disclosure | Disclosure that members of the Johnson family, including Abigail P. Johnson, are predominant owners of Series B voting common shares of FMR LLC (49% voting power) and have a shareholders' voting agreement, forming a controlling group with respect to FMR LLC. | N/A | This details the internal governance structure of the reporting entity (FMR LLC) and its control persons, not a change in Pulmonx Corp's corporate governance. It clarifies the ultimate control over the reported shares. |
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by FMR LLC may enhance investor confidence and potentially attract further investment, positively impacting shareholder value.
Key Dates
| Date | Description |
|---|---|
| 05/23/2023 | Effective date of Power of Attorney for Richard Bourgelas to sign on behalf of FMR LLC and Abigail P. Johnson. |
| 08/08/2023 | Date of previous Schedule 13G filing by FMR LLC where the Power of Attorney was incorporated by reference. |
| 06/30/2025 | Date of event which required the filing of this statement, reflecting the beneficial ownership stake. |
| 08/05/2025 | Date the Schedule 13G Amendment No. 4 was signed and filed. |
Keywords
Pulmonx Corp, FMR LLC, Abigail P. Johnson, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Medical Devices, Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.